Analyst Reco. PROCEPT BioRobotics Corporation

Equities

PRCT

US74276L1052

Market Closed - Nasdaq Other stock markets 01:30:00 27/04/2024 am IST			5-day change	1st Jan Change
51.83 ^USD	-0.86%		+3.27%	+23.67%

21/03	Procept Biorobotics Insider Sold Shares Worth $263,243, According to a Recent SEC Filing	MT
08/03	Procept Biorobotics Insider Sold Shares Worth $428,384, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Procept Biorobotics Insider Sold Shares Worth $263,243, According to a Recent SEC Filing	21/03	MT
Wells Fargo Adjusts Price Target on PROCEPT BioRobotics to $47 From $44, Maintains Overweight Rating	09/01	MT
Truist Securities Raises Price Target on PROCEPT BioRobotics to $50 From $48, Maintains Buy Rating	22/12	MT
Wells Fargo Raises Price Target on PROCEPT BioRobotics to $44 From $40, Maintains Overweight Rating	13/12	MT
B. Riley Lowers PROCEPT BioRobotics' PT to $55 From $60 on Lower Multiple, Keeps Buy Rating	02/11	MT
Piper Sandler Initiates PROCEPT BioRobotics at Overweight With $42 Price Target	11/23/11	MT
William Blair Initiates PROCEPT BioRobotics at Outperform Rating	31/23/31	MT
Truist Adjusts Price Target on PROCEPT BioRobotics to $49 From $54, Keeps Buy Rating	01/23/01	MT
KeyBanc Adjusts Price Target on PROCEPT BioRobotics to $47 From $48, Maintains Overweight Rating	01/23/01	MT
BofA Securities Adjusts PROCEPT BioRobotics' Price Target to $44 From $52, Keeps Buy Rating	28/23/28	MT
Truist Adjusts PROCEPT BioRobotics' Price Target to $49 From $54, Keeps Buy Rating	28/23/28	MT
Truist Securities Trims Price Target on PROCEPT BioRobotics to $55 From $58, Maintains Buy Rating	31/23/31	MT
Wells Fargo Adjusts Price Target on PROCEPT BioRobotics to $43 From $52, Maintains Overweight Rating	12/23/12	MT
Wells Fargo Adjusts Price Target on PROCEPT BioRobotics to $52 From $49, Maintains Overweight Rating	12/22/12	MT
Truist Securities Adjusts PROCEPT BioRobotics Price Target to $58 From $56, Maintains Buy Rating	14/22/14	MT
KeyBanc Capital Markets Adjusts Price Target on PROCEPT BioRobotics to $48 From $47, Maintains Overweight Rating	04/22/04	MT
B. Riley Raises PROCEPT BioRobotics' Price Target to $60 From $53, Keeps Buy Rating	04/22/04	MT
BTIG Starts PROCEPT BioRobotics at Neutral	31/22/31	MT
Truist Securities Starts PROCEPT BioRobotics at Buy With $58 Price Target	25/22/25	MT
Wells Fargo Starts PROCEPT BioRobotics at Overweight With $49 Price Target	02/22/02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. PROCEPT BioRobotics Corporation

Equities

PRCT

US74276L1052

Analyst Reco.

Filters